Stay updated on Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial

Sign up to get notified when there's something new on the Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page shows only minor formatting/layout tweaks with no updates to essential study data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T21:05:33.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    Updated operating-status notice and version to v3.2.0; removed a specific resource entry (Carcinoma of esophagus).
    Difference
    3%
    Check dated 2025-10-06T05:41:17.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T03:09:44.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.
    Difference
    0.2%
    Check dated 2025-09-14T19:19:41.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T15:46:27.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, as well as new resources related to esophageal carcinoma and specific drugs like epacadostat and pembrolizumab. However, many previously listed locations and detailed genetic disease resources have been removed.
    Difference
    3%
    Check dated 2025-08-31T11:55:06.000Z thumbnail image

Stay in the know with updates to Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Epacadostat Plus Pembrolizumab in Gastric Cancer Clinical Trial page.